Please assess the completion status of the following clinical trial:

Trial Title: Two Treatment Regimens of Cocamide DEA Lotion for Head Lice

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female patients over the age of 4 who are found to have a head louse infection.~* Patients who give written informed consent and, if the patient is under 16 years of age, whose guardian gives written informed consent to participate in the study.~* Available for the duration of study i.e. 15 days.~Exclusion Criteria:~* Patients with a known sensitivity to paraben preservatives.~* Patients who have been treated with other head lice products within the last 2 weeks.~* Patients who have undergone a course of antibiotic treatment within the last 4 weeks.~* Patients who have any persistent skin disorder of the scalp (i.e. eczema, chronic dermatitis, psoriasis).~* Patients whose hair has been bleached, colour treated or permed within the last 4 weeks.~* Patients who have participated in another clinical trial within 1 month prior to entry to this study.~* Patients who have already participated in this clinical trial.

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 10% Cocamide diethanolamine 8 hours (Type: EXPERIMENTAL): Cocamide DEA topical lotion applied 8 hours/overnight with drying
- 10% Cocamide diethanolamine 2 hours (Type: EXPERIMENTAL): Cocamide DEA topical lotion applied 2 hours with drying, repeated after 7 days

Based on this trial design, predict the completion outcome and termination type (if applicable).